AI in Drug Discovery

AI investment in drug design and discovery has surged, reaching over $13.8 billion, a significant increase from 2019. This trend highlights the growing importance of AI in tackling complex biological data, particularly in genomics and bioinformatics. Experts' involvement in guiding AI models remains a crucial consideration as the industry evolves.